Search Results 1821-1830 of 16106 for Epilepsy (Partial Onset)

1. A study to assess the safety and efficacy of MANP, a new blood pressure lowering mediation in African Americans with high blood pressure. - Mayo Clinic

   History of epilepsy or other seizure disorder. History of organ transplantation. Malignancy within 5 years. Clinically significant intrinsic renal disease ...

2. A Study of Silent Cerebral Lesions in Patients Undergoing Left Heart Ablation for Ventricular Arrhythmia and Atrial Fibrillation - Mayo Clinic

   Controls in group B will be matched to AF ablation subjects (group A) for age, gender and duration of AF. Controls will be derived from those already ...

3. Celiac Disease Clinical Trials - Mayo Clinic Research

   The purpose of this study is to identify mediators—innate immune system and intestinal permeability—of acute onset gastrointestinal symptoms after gluten ...

4. Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab - Mayo Clinic

   New onset or signs and symptoms of any form of chronic urticarias other than CSU during the preceding studies CQGE031C2302, CQGE031C2303 or CQGE031C2202.

5. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

   International normalized ratio (INR) ≤1.5 × ULN and activated partial ... duration of the study. 9. Major surgery within 4 weeks before the first dose of ...

6. Lacosamide in Patients With Painful Chronic Pancreatitis - Mayo Clinic

   Patient who has a diagnosis of epilepsy and/or is currently taking anti-epileptic drugs. Abdominal surgery or pain intervention (ERCP with sphincterotomy ...

7. Mayo Clinic Comprehensive Cancer Center — Research

   The dosing, duration, regimen, indication, and treatments will be observed. ... partial response (VGPR) or better rate. Pagination Clinical studies. Prev ...

8. A Study to Treat Patients with Dravet Syndrome Using ZX008 - Mayo Clinic

   ... seizure history, prior and current therapies, response to prior therapies, reason for request, and why the patient lacks other therapeutic options.

9. A Study of the Safety and Effectiveness of NP001 for Patients with Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation - Mayo Clinic

   Onset of ALS-related weakness less than 3 years prior to first dose of study drug; Plasma high sensitivity C-reactive protein (hs-CRP) concentration of ...

10. Anxiety Disorders Clinical Trials

    ... epilepsy Rochester, MN. This study aims to assess the level of anxiety and depression in children with epilepsy and compare to the level of anxiety and ...